| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/10/2005 | CA2534711A1 Combination therapies for multiple sclerosis |
| 02/10/2005 | CA2534639A1 Anti-cd19 antibodies |
| 02/10/2005 | CA2534461A1 An agent for preventing and/or treating hematologic malignancies |
| 02/10/2005 | CA2534377A1 Method for immunotherapy of tumors |
| 02/10/2005 | CA2534351A1 Accelerated vaccination |
| 02/10/2005 | CA2534327A1 Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints |
| 02/10/2005 | CA2534077A1 Antibodies and methods for generating genetically altered antibodies with enhanced effector function |
| 02/10/2005 | CA2533918A1 Use of adcc-optimized antibodies for treating weak patients |
| 02/10/2005 | CA2533593A1 Altered antibodies having improved antigen-binding affinity |
| 02/10/2005 | CA2533559A1 Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof |
| 02/10/2005 | CA2533512A1 Antagonists and agonists of ldcam and methods of use |
| 02/10/2005 | CA2531684A1 Binding molecules against sars-coronavirus and uses thereof |
| 02/10/2005 | CA2531441A1 Hybrid toxins comprising shiga or shiga-like toxin subunits fused to escherichia coli heat labile enterotoxin subunits and vaccines thereof |
| 02/10/2005 | CA2531329A1 Family of 28 kda babesia proteins as vaccines |
| 02/10/2005 | CA2530172A1 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/10/2005 | CA2529798A1 Methods of treating hepatocellular carcinoma with zvegf3 antagonists |
| 02/09/2005 | EP1505153A1 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 02/09/2005 | EP1505076A2 Specific antibody fragments for the human carcinoembryonic antigen (cea) |
| 02/09/2005 | EP1505075A1 Antibody to human insulin-like growth factor |
| 02/09/2005 | EP1504764A1 Treatment of liver fibrosis with antagonists of alpha V beta 6 integrin |
| 02/09/2005 | EP1504124A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions |
| 02/09/2005 | EP1504112A2 Development of a preventive vaccine for filovirus infection in primates |
| 02/09/2005 | EP1504107A1 Recombinant fowlpox virus |
| 02/09/2005 | EP1504095A2 Site specific listeria integration vectors and methods for using the same |
| 02/09/2005 | EP1504037A2 Ferritin fusion proteins for use in vaccines and other applications |
| 02/09/2005 | EP1504035A2 Antibodies specific for human cd22 and their therapeutic and diagnostic uses |
| 02/09/2005 | EP1504034A1 Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
| 02/09/2005 | EP1504027A2 Adipocyte complement related protein zacrp8 |
| 02/09/2005 | EP1504025A2 Nucleic acids and proteins from streptococcus groups a & b |
| 02/09/2005 | EP1503801A2 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 02/09/2005 | EP1503799A2 Immunogenic, monoclonal antibody |
| 02/09/2005 | EP1503795A2 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 02/09/2005 | EP1503794A1 Methods of treatement using ctla-4 antibodies |
| 02/09/2005 | EP1503793A2 Cancer vaccines and methods of using the same |
| 02/09/2005 | EP1503792A2 Attenuation of metapneumovirus |
| 02/09/2005 | EP1503791A2 Methods of therapy for inducing tolerance |
| 02/09/2005 | EP1503787A1 Compositions and methods for diagnosis and treatment of cardiovascular disorders |
| 02/09/2005 | EP1503785A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 02/09/2005 | EP1503781A1 Treatment for weight loss |
| 02/09/2005 | EP1503779A2 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 02/09/2005 | EP1503745A2 15625 receptor, a novel g-protein coupled receptor |
| 02/09/2005 | EP1079813B1 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 02/09/2005 | EP1056860B1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 02/09/2005 | EP1030923B1 Method for producing virus-like particles on the basis of polyoma viruses |
| 02/09/2005 | EP0966301B1 Identification of human cytomegalovirus genes involved in down-regulation of mhc class i heavy chain expression |
| 02/09/2005 | EP0843818B1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents |
| 02/09/2005 | EP0700438B1 Opioid receptors: compositions and methods |
| 02/09/2005 | CN1578788A Pharmaceutical compositions, and a method of preparing and isolating said pharmaceutical compositions, and use of said pharmaceutical compositions for prophylactic treatment of lesions and carcinomas |
| 02/09/2005 | CN1578785A Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 02/09/2005 | CN1578678A Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 02/09/2005 | CN1578673A Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders |
| 02/09/2005 | CN1578672A Rsv基因表达疫苗 Rsv gene expression vaccine |
| 02/09/2005 | CN1578647A Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| 02/09/2005 | CN1576840A Methods for diagnosis and therapy of cancer and composition useful therein |
| 02/09/2005 | CN1576281A Viral clearance process |
| 02/09/2005 | CN1576275A Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 02/09/2005 | CN1575819A Use of melanoma differentiation associated gene (mda-7) for reversing cancerous phenotype |
| 02/09/2005 | CN1575815A Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 02/09/2005 | CN1188528C Intercellular adhesion molecule-3 and its binding ligands |
| 02/09/2005 | CN1188519C Fusion proteins comprising HIV-1 Tat and /or Nef proteins |
| 02/09/2005 | CN1188426C Antibodise against phosphorylated VASP (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
| 02/09/2005 | CN1188169C Use of antibodies for anticancer vaccination |
| 02/09/2005 | CN1188168C Vaccine compsn |
| 02/09/2005 | CN1188167C Method of controlling the qualities of attenuated pox vaccine |
| 02/09/2005 | CN1188111C Dry powder compositions having improved dispersivity |
| 02/08/2005 | US6852847 B7 nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins and inhibitors of such proteins or nucleic acid molecules |
| 02/08/2005 | US6852839 Fhm, a novel member of the TNF ligand supergene family |
| 02/08/2005 | US6852838 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders |
| 02/08/2005 | US6852705 DNA vaccines for farm animals, in particular bovines and porcines |
| 02/08/2005 | US6852703 A vector comprising a nucleotide sequence of interest ("NOI") encoding a product of interest ("POI") is described. The NOI and/or the POI is capable of recognizing a tumor, such that in use the vector is capable of delivering the NOI and/or the POI |
| 02/08/2005 | US6852522 Methods and interferon deficient substrates for the propagation of viruses |
| 02/08/2005 | US6852520 DSP-2 dual-specificity phosphatase |
| 02/08/2005 | US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6 |
| 02/08/2005 | US6852509 Anti-P53 single-chain antibody fragments and their uses |
| 02/08/2005 | US6852508 Chemokine with amino-terminal modifications |
| 02/08/2005 | US6852486 Detection of leukocyte antigen in sample; obtain cell sample, incubate with bindng protein, detect bound protein, presence of bound protein indicates leukocyte antigen presence |
| 02/08/2005 | US6852322 Surface proteins of Leptospira |
| 02/08/2005 | US6852320 T cell inhibitory receptor compositions and uses thereof |
| 02/08/2005 | US6852230 Method for the manufacture of compositions containing low concentrations of salts |
| 02/08/2005 | CA2323450C Assay of igfbp complex |
| 02/08/2005 | CA2184183C Inhibin compositions and methods of use thereof |
| 02/08/2005 | CA2180103C Gene encoding adseverin |
| 02/03/2005 | WO2005010173A2 Keratinocyte culturing method and the use thereof |
| 02/03/2005 | WO2005010167A2 Antibodies to the fbsa protein of streptococcus agalactiae and their use in treating or preventing infections |
| 02/03/2005 | WO2005010163A2 Compositions and methods for immunotherapy of human immunotherapy of human immunodeficiency virus (hiv) |
| 02/03/2005 | WO2005010152A2 Human mast cell-expressed membrane protein |
| 02/03/2005 | WO2005010151A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/03/2005 | WO2005010050A1 Hetero type pentamer recombinant vaccine |
| 02/03/2005 | WO2005010042A1 7a5/prognostin and use thereof for the diagnostic and therapy of tumors |
| 02/03/2005 | WO2005010040A1 Eimeria tenella antigen for immunotherapy of coccidiosis |
| 02/03/2005 | WO2005010037A1 Polypeptides, nucleic acids coding therefor, from the mold fungus cladosporium herbarum and the production and use thereof in diagnosis and therapy |
| 02/03/2005 | WO2005010036A1 Vaccine and compositions for the prevention and treatment of neisserial infections |
| 02/03/2005 | WO2005010035A2 Alternate reading frame polypeptides derived from hepatitis c and methods of their use |
| 02/03/2005 | WO2005010034A1 Soluble fragments of the sars-cov spike glycoprotein |
| 02/03/2005 | WO2005010033A1 New soluble and stabilized trimeric form of gp41 polypeptides |
| 02/03/2005 | WO2005010032A2 Replikin peptides and uses thereof |
| 02/03/2005 | WO2005010023A2 Method for prediction of an epitope |
| 02/03/2005 | WO2005009464A1 Administration of anti-cytokine f(ab')2 antibody fragments |
| 02/03/2005 | WO2005009463A2 Antigen-presenting cell vaccines and methods of use thereof |
| 02/03/2005 | WO2005009462A2 Vaccine formulations comprising an oil-in-water emulsion |